Patents/Assignees

Mainline Biosciences (Shanghai) Co., Ltd.

2 patents in portfolio

US11883501utility2024
Selective CXCR4 Binding Peptide Conjugate and Methods for Making and Using the Same
0 cites
US11771736utility2023
Composition Comprising a Therapeutic Agent and a CXCR4 Selective Antagonist and Methods for Using the Same
0 cites